Odyssey Therapeutics, Inc. Common Stock (ODTX) is a publicly traded the market company. As of October 6, 2026, ODTX trades at $20.84 with a market cap of $996.01M and a P/E ratio of 0.00. ODTX moved +0.84% today. Year to date, ODTX is +0.00%; over the trailing twelve months it is flat. Its 52-week range spans $15.10 to $29.05. Analyst consensus is strong buy with an average price target of $34.33. Rallies surfaces ODTX's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
ODTX financials on Rallies include revenue, net income, EPS, valuation metrics, market cap, price history, and balance sheet context. ODTX recently traded at $20.84. Market cap is $996.01M. P/E ratio is 0.00. Revenue is $0.
| Metric | Value |
|---|---|
| Price | $20.84 |
| Market Cap | $996.01M |
| P/E Ratio | 0.00 |
| EPS | $0.00 |
| Dividend Yield | 0.00% |
| 52-Week High | $29.05 |
| 52-Week Low | $15.10 |
| Volume | 0 |
| Avg Volume | 0 |
| Revenue (TTM) | $0 |
| Net Income | $0 |
| Gross Margin | 0.00% |
4 analysts cover ODTX: 0 strong buy, 4 buy, 0 hold, 0 sell, 0 strong sell. Consensus rating is strong buy. Average price target: $34.33.